Antimetabolites: all 7,305 studies that test it
Page 46 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by SurgeryActive, not recruitingNCT02336087Phase 1
- Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid MalignanciesStatus unknownNCT02333838Phase 2
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantSuspendedNCT02333162Phase 1
- Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal CancerStatus unknownNCT02325986Phase 2
- Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of FluoropyrimidinesCompletedNCT02324452Not applicable
- Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell LymphomasTerminatedNCT02323659Phase 4
- A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome PatientsCompletedNCT02323139Phase 1
- Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT02319135Phase 3
- Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02316964Phase 1
- Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal CancerStatus unknownNCT02316535Phase 3
- Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and BevacizumabCompletedNCT02316327Phase 4
- Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)CompletedNCT02316028Phase 1/2
- Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidCompletedNCT02313870Phase 3
- Maintenance Treatment Versus Observation in Elderly Patients With PCNS LymphomaStatus unknownNCT02313389Phase 3
- Augmentation of Cognitive Training in Children With TBI With D-CyloserineStatus unknownNCT02312635Early Phase 1
- Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)TerminatedNCT02310997Phase 2
- Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer PatientsCompletedNCT02309658Phase 2
- Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian CancerCompletedNCT02303912Phase 1
- Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural MesotheliomaCompletedNCT02303899Phase 2
- A Study Assessing tOTX015 in Combination With Azacitidine (AZA) or AZA Single Agent in Patients With Newly-diagnosed Acute Myeloid Leukemia (AML) Not Candidate for Standard Intensive Induction Therapy (SIIT)WithdrawnNCT02303782Phase 1/2
- A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric AdenocarcinomaCompletedNCT02301481Phase 2
- A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal ImpairmentCompletedNCT02301117Phase 1
- A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic ImpairmentCompletedNCT02301104Phase 1
- Effects of Metyrapone in Patients With Endogenous Cushing's SyndromeCompletedNCT02297945Phase 3
- Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic MarkersWithdrawnNCT02296671Phase 2
- A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric CancerStatus unknownNCT02296658Phase 2
- GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory LymphomaTerminatedNCT02295722Phase 1/2
- Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
- Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric CancerStatus unknownNCT02289547Phase 3
- Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric CancerStatus unknownNCT02289378Phase 2
- Therapeutic Response Evaluation and Adherence Trial (TREAT)Active, not recruitingNCT02286154Not applicable
- Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal CancerCompletedNCT02284529Phase 4
- High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain MetastasesStatus unknownNCT02284490Phase 2
- Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02283372Phase 1
- Thiopurine Induced Pancreatitis in IBD PatientsWithdrawnNCT02281799Phase 4
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic KeratosisStatus unknownNCT02281682Phase 4
- Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma PatientsStatus unknownNCT02280993Phase 1
- Low Dose Metronomic Poly-chemotherapy for Metastatic CRCCompletedNCT02280694Phase 2
- RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).Status unknownNCT02280070Phase 2
- Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic MelanomaCompletedNCT02278887Phase 3
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic CancerStatus unknownNCT02278458Phase 1
- Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid LeukaemiaStatus unknownNCT02277847Phase 4
- Azacytidine Plus FLAG for Relapsed or Refractory AMLStatus unknownNCT02275663Phase 2
- p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial CancerCompletedNCT02275039Phase 1
- Infusion of Allogeneic, 3rd Party CD19-specific T CellsWithdrawnNCT02274506Phase 1
- A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerCompletedNCT02272738Phase 1
- Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy CombinationsStatus unknownNCT02272478Phase 2/3
- Maintenance Bevacizumab Only or Bevacizumab Plus Metronomic Chemotherapy in Advanced Colorectal CancerCompletedNCT02271464Phase 2
- Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerCompletedNCT02270606Phase 1
- Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic ImpairmentWithdrawnNCT02269579Phase 2
- Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose EscalationCompletedNCT02269358Phase 4
- IMRT-SIB and Capecitabine in Preoperative Rectal Cancer TreatmentStatus unknownNCT02268006Phase 2
- Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic HyperbilirubinemiaTerminatedNCT02267707Phase 1
- Phase I, Dose Escalation Study of DecitabineCompletedNCT02264873Phase 1
- Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast CancerCompletedNCT02253459Phase 3
- 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1CompletedNCT02252107Phase 2
- Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT02250937Phase 2
- Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.Status unknownNCT02248792Phase 4
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.TerminatedNCT02247258Phase 2
- Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal CancerCompletedNCT02244632Phase 1/2
- Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT02244489Phase 1
- Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin LymphomaCompletedNCT02243436Phase 1/2
- Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic KeratosisCompletedNCT02242747Not applicable
- Study of Gemcitabine and Abraxane for Pancreas CancerTerminatedNCT02242409Phase 2
- Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?CompletedNCT02237339Phase 4
- Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid TumorsCompletedNCT02235688Phase 1
- Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal CancerWithdrawnNCT02235324Phase 2
- Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60TerminatedNCT02234037Phase 1
- Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive SystemStatus unknownNCT02233205Phase 1/2
- CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT02232152Phase 1
- Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric CancerStatus unknownNCT02229045Phase 2
- Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02227940Phase 1
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic CancerTerminatedNCT02215044Phase 1
- Randomized Phase III Study of Decitabine +/- Hydroxyurea (HY) Versus HY in Advanced Proliferative CMMLCompletedNCT02214407Phase 3
- Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic SyndromeCompletedNCT02212561Phase 1
- Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid TumorsCompletedNCT02211755Phase 1
- Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).CompletedNCT02210364Phase 1
- LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell HistiocytosisActive, not recruitingNCT02205762Phase 2/3
- Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDSWithdrawnNCT02204020Phase 2
- Pazopanib Vs. Pazopanib Plus GemcitabineActive, not recruitingNCT02203760Phase 2
- Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the BladderActive, not recruitingNCT02202772Phase 1/2
- The Safety and Efficacy of Pemetrexed Rechallenge With BevacizumabTerminatedNCT02200354Phase 2
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Active, not recruitingNCT02194738Not applicable
- Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLCStatus unknownNCT02194556Phase 4
- Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)WithdrawnNCT02194374Phase 1
- GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract CancerCompletedNCT02182778Phase 3
- Intra-Osseous Co-Transplant of UCB and hMSCCompletedNCT02181478Early Phase 1
- Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive LymphomasCompletedNCT02181218Phase 1
- Window Trial 5-aza in HNSCC, T-tareCompletedNCT02178072Phase 1
- A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyCompletedNCT02177071Phase 4
- Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLCCompletedNCT02175381Phase 1/2
- Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerCompletedNCT02174887Phase 1
- Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas CarcinomaCompletedNCT02172976Phase 2/3
- "InDACtion" vs "3+7" Induction in AMLStatus unknownNCT02172872Phase 3
- Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract CancerActive, not recruitingNCT02170090Phase 3
- Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceCompletedNCT02167958Phase 1
- Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain MetastasesTerminatedNCT02162537Phase 3